Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
36716004
PubMed Central
PMC10090889
DOI
10.2337/dc22-1952
PII: 148378
Knihovny.cz E-resources
- MeSH
- Bariatric Surgery * adverse effects MeSH
- Diabetes Mellitus, Type 2 * complications surgery MeSH
- Duodenum surgery MeSH
- Cardiovascular Diseases * surgery MeSH
- Humans MeSH
- Obesity, Morbid * complications surgery MeSH
- Obesity complications surgery MeSH
- Risk Factors MeSH
- Treatment Outcome MeSH
- Gastric Bypass * adverse effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Adelaide Bariatric Centre Flinders Medical Centre Bedford Park Australia
Atrium Medical Center Parkstad Heerlen the Netherlands
Catharina Hospital Eindhoven the Netherlands
Department of Gastroenterology and Hepatology Princess Alexandra Hospital Woolloongabba Australia
Diabetes and Endocrinology Guy's and St Thomas' Hospital London U K
Diabetes Centre Institute for Clinical and Experimental Medicine Praha Czech Republic
Diabetes Diakonissensanstalt Emmaus Niesky Niesky Germany
Diabetes Endocrinology and Clinical Pharmacology University of Glasgow Glasgow U K
Endokrinologie und Diabetologie Universitätsklinikum Hamburg Eppendorf Ringgold Hamburg Germany
Epworth Centre for Bariatric Surgery Richmond Australia
Gastroenterology Imperial College London London U K
Gastroenterology Manchester University National Health Service Foundation Trust Manchester U K
Gastroenterology Tel Aviv Sourasky Medical Center Tel Aviv Israel
General Surgery Maastricht UMC Maastricht the Netherlands
Medical Faculty University of Ljubljana Ljubljana Slovenia
Metabolic and Bariatric Surgery Maastricht UMC Maastricht the Netherlands
Specialized Center for Obesity and Diabetes Hospital Alemão Oswaldo Cruz São Paulo Brazil
Surgery Calvary North Adelaide Hospital Adelaide Australia
Surgery University Hospital Southampton National Health Service Foundation Trust Southampton U K
Sydney Adventist Hospital Wahroonga Australia
See more in PubMed
International Diabetes Federation . Diabetes around the world in 2021. In: IDF Diabetes Atlas, 10th ed. Brussels, Belgium, International Diabetes Federation, 2021. Accessed 14 October 2022. Available from https://diabetesatlas.org/
Jirapinyo P, Haas AV, Thompson CC. Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes. Diabetes Care 2018;41:1106–1115 PubMed
Ryder REJ, Irwin SP, Burbridge W, et al. . The United Kingdom’s first NHS EndoBarrier service for advanced diabesity: 1-year outcomes for all 62 treated patients. Br J Diabetes 2019;19:110–117
Ryder REJ, Yadagiri M, Burbridge W, et al. . Duodenal-jejunal bypass liner for treatment of type 2 diabetes and obesity: 4-year outcomes in the first National Health Service (NHS) EndoBarrier service. Br J Diabetes 2022;22:82–86 PubMed PMC
GI Dynamics . EndoBarrier system pivotal trial (Rev E) (STEP-1). In: ClinicalTrials.gov. Bethesda, MD, National Library of Medicine, 2000. NLM Identifier: NCT04101669. Accessed 14 October 2022. Available from https://clinicaltrials.gov/ct2/show/NCT04101669